Assignee
NEURODON CORP
US·5 granted patents·1 pending application·3 citations·filing 2021–2024
Top patents by PatentIndex Score
6 records- 0193US11890279B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2023·Granted Feb 6, 2024·1 cites·4 claims
- 0289US11730729B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2021·Granted Aug 22, 2023·1 cites·4 claims
- 0387US12144806B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2024·Granted Nov 19, 2024·0 cites·5 claims
- 0487US11827626B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2021·Granted Nov 28, 2023·1 cites·8 claims
- 0586US2025248990A1Quinolines that modulate serca and their use for treating diseaseNEURODON CORP·Filed 2024·Application pending·0 cites
- 0685US11992487B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2023·Granted May 28, 2024·0 cites·1 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →